Efficacy of rituximab in dermatomyositis and polymyositis refractory to conventional therapy.

Abstract

We report one case of dermatomyositis and one of polymyositis refractory to several conventional inmunosupressive therapies, which present a response after treatment with rituximab, enabling steroid dose reduction and a prolonged remission.

• Authors: Simón Ángel Sánchez-Fernández, José Antonio Carrasco Fernández, Luisa Marena Rojas Vargas
• Journal: Reumatologia clinica (Reumatol Clin) 2013 Mar-Apr Vol. 9 Issue 2 Pg. 117-9 ISSN: 1885-1398 [Electronic] Spain
• PMID: 22771272 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2012 Elsevier España, S.L. All rights reserved.

Chemical References

• Antibodies, Monoclonal, Murine-Derived
• Immunologic Factors
• Rituximab

Topics

• Adult
• Antibodies, Monoclonal, Murine-Derived (therapeutic use)
• Dermatomyositis (drug therapy)
• Female
• Humans
• Immunologic Factors (therapeutic use)
• Middle Aged
• Polymyositis (drug therapy)
• Rituximab